Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE.

Carcinogenesis. 2011 Jan;32(1):69-73. doi: 10.1093/carcin/bgq204. Epub 2010 Oct 7.

2.

Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer.

Rajaee-Behbahani N, Schmezer P, Risch A, Rittgen W, Kayser KW, Dienemann H, Schulz V, Drings P, Thiel S, Bartsch H.

Int J Cancer. 2001 Mar 20;95(2):86-91.

3.

Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report.

Zhang H, Buchholz TA, Hancock D, Spitz MR, Wu X.

Int J Oncol. 2000 Aug;17(2):399-404.

PMID:
10891553
4.

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR.

Am J Hum Genet. 2006 Mar;78(3):464-79. Epub 2006 Jan 31.

5.

Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.

Li D, Firozi PF, Wang LE, Bosken CH, Spitz MR, Hong WK, Wei Q.

Cancer Res. 2001 Feb 15;61(4):1445-50. Erratum in: Cancer Res 2001 Apr 15;61(8):3531.

6.

Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.

Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR.

Carcinogenesis. 1998 Jan;19(1):93-8.

PMID:
9472699
7.

Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.

Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, Hwang LY.

Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):567-70.

8.

Bleomycin-induced mutagen sensitivity, passive smoking, and risk of breast cancer in Chinese women: a case-control study.

Hu M, Han D, Sun S, Yan Y, Zhang J, Zhou Y.

Cancer Causes Control. 2013 Apr;24(4):629-36. doi: 10.1007/s10552-012-0137-1. Epub 2013 Feb 1.

PMID:
23371556
9.

Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.

Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR.

J Natl Cancer Inst. 2000 Nov 1;92(21):1764-72.

PMID:
11058619
10.

Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk.

Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR.

Int J Cancer. 2007 Jun 15;120(12):2687-95.

11.

A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma.

Wang L, Wei Q, Shi Q, Guo Z, Qiao Y, Spitz MR.

Carcinogenesis. 2007 Jul;28(7):1430-6. Epub 2007 Mar 6.

PMID:
17341660
12.

Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.

Strom SS, Wu S, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG, Spitz MR.

J Natl Cancer Inst Monogr. 1995;(18):29-33.

PMID:
8562219
13.

Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.

Wu X, Yu H, Amos CI, Hong WK, Spitz MR.

J Natl Cancer Inst. 2000 May 3;92(9):737-43.

PMID:
10793110
14.

Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.

Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR.

Cancer Res. 2002 May 15;62(10):2813-8.

15.

Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.

He Y, Gong Y, Lin J, Chang DW, Gu J, Roth JA, Wu X.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):443-51. doi: 10.1158/1055-9965.EPI-12-0794. Epub 2013 Jan 8.

16.

Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes.

Schmezer P, Rajaee-Behbahani N, Risch A, Thiel S, Rittgen W, Drings P, Dienemann H, Kayser KW, Schulz V, Bartsch H.

Mutagenesis. 2001 Jan;16(1):25-30.

PMID:
11139596
17.

Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.

Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG.

Carcinogenesis. 2003 Feb;24(2):269-74. Erratum in: Carcinogenesis. 2003 Aug;24(8):1425.

PMID:
12584177
18.

Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.

Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei Q.

Clin Cancer Res. 1998 Jul;4(7):1773-8.

19.

Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.

Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, Bosken CH, Amos CI, Wei Q.

Int J Cancer. 2003 Oct 20;107(1):84-8.

20.

Mutagen sensitivity as a marker of cancer susceptibility.

Spitz MR, Wu X, Jiang H, Hsu TC.

J Cell Biochem Suppl. 1996;25:80-4.

PMID:
9027602

Supplemental Content

Support Center